Trial Profile
Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary)
- Indications Leukaemia
- Focus Pharmacokinetics
- 10 Apr 2015 Status changed from recruiting to active, no longer recruiting as per results presented at the 56th Annual Meeting and Exposition of the American Society of Hematology.
- 18 Nov 2011 New trial record